Ocular Therapeutix, Inc. (OCUL)

9.58 +0.62 (+6.98%) USD  |  NASDAQ  |  Feb 25, 11:53
More

Ocular Therapeutix Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Boston Scientific Corp. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
EyePoint Plc Upgrade
Vertex Pharmaceuticals, Inc. Upgrade